Holen Sie sich die Stockscreener-App
3.90
2.28%
-0.05
60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten
60 Degrees Pharmaceuticals company regained compliance with Nasdaq minimum bid price - marketscreener.com
60 Degrees Pharmaceuticals Regains Nasdaq Listing Compliance Status - TipRanks
60 Degrees Pharmaceuticals Regains Nasdaq Compliance - TradingView
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant a top pick in the sectorPortfolio Value Report & Short-Term Swing Trade Alerts - mfd.ru
Returns Recap: Is Hut 8 Corp stock suitable for long term investingTrade Exit Summary & AI Optimized Trading Strategy Guides - baoquankhu1.vn
60 Degrees Pharmaceuticals (SXTP) Price Target Increased by 300.00% to 17.95 - Nasdaq
RSI Check: Can 60 Degrees Pharmaceuticals Inc. be recession proofJuly 2025 Fed Impact & Short-Term Trading Alerts - baoquankhu1.vn
Quarterly Trades: Can 60 Degrees Pharmaceuticals Inc. Equity Warrant maintain sales growth2025 Key Highlights & Verified Short-Term Trading Plans - baoquankhu1.vn
60 Degrees Pharmaceuticals, Inc. (SXTP) Stock: Pulls Back as GoodRx Partnership Fails to Lift Sentiment - parameter.io
60 Degrees Pharmaceuticals Partners with GoodRx to List FDA-Approved Antimalarial Drug ARAKODA for Price Comparisons - geneonline.com
60 Degrees Pharmaceuticals stock falls after GoodRx partnership announcement - Investing.com
Malaria prevention pill ARAKODA gets GoodRx discounts at 70,000 pharmacies - Stock Titan
Rate Cut: How does 60 Degrees Pharmaceuticals Inc score in quality rankings2025 Market WrapUp & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Patterns Watch: Can 60 Degrees Pharmaceuticals Inc Equity Warrant continue delivering strong returns - baoquankhu1.vn
HC Wainwright Has Bearish Estimate for SXTP FY2025 Earnings - Defense World
60 Degrees Pharmaceuticals shares slide after Nasdaq flags delisting risk - MSN
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Visalia Times-Delta
Short Covering: Can 60 Degrees Pharmaceuticals Inc. be recession proofWeekly Profit Recap & Capital Efficient Trade Techniques - mfd.ru
60 Degrees Pharma exercises option for castanospermine extraction By Investing.com - Investing.com Nigeria
Ideas Watch: Is Cassava Sciences Inc Equity Warrant in a consolidation phaseAnalyst Upgrade & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Market Catalysts: Can 60 Degrees Pharmaceuticals Inc Equity Warrant maintain sales growth2025 Trade Ideas & Expert Curated Trade Setups - baoquankhu1.vn
60 Degrees Pharma exercises option for castanospermine extraction - Investing.com
60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use - The Manila Times
Runway Health Partnership and Multi-Pronged Commercial Strategy Underpin Buy Rating on 60 Degrees Pharmaceuticals - TipRanks
60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Times Herald-Record
What Does the Market Think About 60 Degrees Pharmaceuticals Inc? - Benzinga
60 Degrees Pharmaceuticals stock tumbles after Nasdaq delisting notice - Investing.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Meme Stocks: Can 60 Degrees Pharmaceuticals Inc Equity Warrant grow without external funding2025 Top Gainers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Times Herald-Record
Guidance Update: Is ATCOPRH part of any major indexJuly 2025 Levels & Daily Momentum Trading Reports - baoquankhu1.vn
60 Degrees Pharmaceuticals faces Nasdaq delisting after minimum bid price violation - Investing.com India
Pharmaceutical Stocks To Consider – January 22nd - Defense World
60 Degrees Pharmaceuticals Faces Immediate Nasdaq Delisting Appeal - TipRanks
60 Degrees Pharmaceuticals Received Notice of Delisting - TradingView
SXTP stock rockets 161% pre-market — what is driving the surge? - MSN
Take Profit: How does 60 Degrees Pharmaceuticals Inc score in quality rankingsProduct Launch & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
60 Degrees Pharmaceuticals stock swings again: SXTP slides in premarket after Runway Health deal pop - TechStock²
60 Degrees Pharma partners with Runway Health for malaria drug access - Investing.com Nigeria
60 Degrees Pharma partners with Runway Health for malaria drug access By Investing.com - Investing.com South Africa
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant maintain sales growth2025 Price Momentum & Real-Time Volume Analysis - mfd.ru
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant exposed to currency risks2025 Market Outlook & AI Driven Price Predictions - mfd.ru
Promising Small Cap Stocks To ConsiderJanuary 22nd - MarketBeat
60 Degrees Pharmaceuticals, Inc. (SXTP) stock: surges 140% after Runway Health partnership announcement - parameter.io
Pharmaceutical Stocks To ConsiderJanuary 22nd - MarketBeat
60 Degrees Pharmaceuticals (SXTP) Stock Surges 150% on Health Malaria Drug Partnership - parameter.io
60 Degrees Pharmaceuticals announces partnership with Runway Health - TipRanks
Crude Oil Down 2%; Abbott Shares Fall Following Q4 Results - Benzinga
60 Degrees Pharmaceuticals Soars After Runway Health Partnership - Benzinga
60 Degrees Combines with Runway, Shares Skyrocket - Baystreet.ca
60 Degrees Pharmaceuticals (SXTP) stock more than triples as Runway Health deal hits tape - TechStock²
SXTP Stock Rockets 161% Pre-MarketWhat Is Driving The Surge? - Menafn
60 Degrees Pharmaceuticals Finds Babesia Link, Shares Climb - StocksToTrade
Dow Jumps 300 Points; Procter & Gamble Shares Gain After Q2 Results - Benzinga
SXTP Stock Rockets 161% Pre-Market — What Is Driving The Surge? - Asianet Newsable
Breakthrough Discovery: Babesia and Chronic Disease Link UncoveredTimothy Sykes - timothysykes.com
Here’s Why 60 Degrees Pharmaceuticals Stock (SXTP) Rocketed Today - TipRanks
0.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):